SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-058351
Filing Date
2022-05-10
Accepted
2022-05-10 17:28:09
Documents
14
Period of Report
2022-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2215074d1_8k.htm   iXBRL 8-K 28351
2 EXHIBIT 99.1 tm2215074d1_ex99-1.htm EX-99.1 59593
6 GRAPHIC tm2215074d1_ex99-1img001.jpg GRAPHIC 7398
  Complete submission text file 0001104659-22-058351.txt   281087

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elox-20220510.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20220510_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20220510_pre.xml EX-101.PRE 22601
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2215074d1_8k_htm.xml XML 3508
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 22911194
SIC: 2836 Biological Products, (No Diagnostic Substances)